Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PEG-encapsulated allogeneic islet cells
- Development stage
- Unknown
- Lead developer
- Eli Lilly
- Modality
- Hydrogel Systems → Drug Delivery Systems, Cell Therapies
- Administration
- Implant
01
Overview
PEG-encapsulated allogeneic islet cells represent a cell-based therapeutic platform designed for the treatment of Type 1 Diabetes. The technology involves the transplantation of donor-derived (allogeneic) pancreatic islet cells that have been encapsulated within a biocompatible polyethylene glycol (PEG) hydrogel or conformal coating. This PEG layer acts as a semi-permeable physical barrier, allowing for the physiological diffusion of glucose, oxygen, and insulin while shielding the transplanted cells from the recipient's immune system, including T-cell mediated rejection and autoantibody attacks. The primary objective of this immunoisolation strategy is to achieve long-term graft survival and functional insulin independence without the requirement for chronic systemic immunosuppression, which is the major limitation of conventional islet transplantation.
- Other names
- PEG-encapsulated isletsencapsulated allogeneic isletsPEG-coated isletsPEG-encapsulated allogeneic pancreatic islet cells
Beyond the preview
Go deeper on PEG-encapsulated allogeneic islet cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PEG-encapsulated allogeneic islet cells.